Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APLD NASDAQ:ARM NASDAQ:CRWV NASDAQ:NBIS NASDAQ:NVDA NASDAQ:RXRX NASDAQ:WRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$27.57-3.2%$41.27$9.75▼$50.72$7.90B5.6724.56 million shs7.62 million shsARMARM$267.09-5.0%$321.30$100.02▼$452.70$286.23B3.768.76 million shs2.90 million shsCRWVCoreWeave$75.18-6.0%$103.54$63.80▼$153.20$33.75B7.1728.26 million shs11.51 million shsNBISNebius Group$188.43-2.9%$228.19$49.00▼$299.86$47.73B4.116.29 million shs9.23 million shsNVDANVIDIA$206.66-2.4%$209.87$164.07▼$236.54$5.01T2.21166.79 million shs49.54 million shsRXRXRecursion Pharmaceuticals$3.34-0.1%$3.34$2.77▼$7.18$1.77B118.33 million shs8.31 million shsWRDWeRide$6.16+0.6%$6.59$5.18▼$12.55$1.92B1.923.67 million shs1.18 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital-1.28%-7.29%-33.33%-7.59%+199.05%ARMARM-5.96%-6.41%-26.17%+76.46%+94.53%CRWVCoreWeave-4.09%-4.30%-20.50%-32.65%-39.61%NBISNebius Group-7.80%-0.56%-16.47%+16.38%+273.61%NVDANVIDIA+3.98%+7.55%+3.22%+6.50%+29.09%RXRXRecursion Pharmaceuticals+1.21%-13.02%+6.03%-10.93%-36.74%WRDWeRide+6.62%+12.71%-0.81%-24.44%-28.92%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$27.57-3.2%$41.27$9.75▼$50.72$7.90B5.6724.56 million shs7.62 million shsARMARM$267.09-5.0%$321.30$100.02▼$452.70$286.23B3.768.76 million shs2.90 million shsCRWVCoreWeave$75.18-6.0%$103.54$63.80▼$153.20$33.75B7.1728.26 million shs11.51 million shsNBISNebius Group$188.43-2.9%$228.19$49.00▼$299.86$47.73B4.116.29 million shs9.23 million shsNVDANVIDIA$206.66-2.4%$209.87$164.07▼$236.54$5.01T2.21166.79 million shs49.54 million shsRXRXRecursion Pharmaceuticals$3.34-0.1%$3.34$2.77▼$7.18$1.77B118.33 million shs8.31 million shsWRDWeRide$6.16+0.6%$6.59$5.18▼$12.55$1.92B1.923.67 million shs1.18 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital-1.28%-7.29%-33.33%-7.59%+199.05%ARMARM-5.96%-6.41%-26.17%+76.46%+94.53%CRWVCoreWeave-4.09%-4.30%-20.50%-32.65%-39.61%NBISNebius Group-7.80%-0.56%-16.47%+16.38%+273.61%NVDANVIDIA+3.98%+7.55%+3.22%+6.50%+29.09%RXRXRecursion Pharmaceuticals+1.21%-13.02%+6.03%-10.93%-36.74%WRDWeRide+6.62%+12.71%-0.81%-24.44%-28.92%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPLDApplied Digital 2.94Moderate Buy$70.56155.93% UpsideARMARM 2.63Moderate Buy$295.2510.54% UpsideCRWVCoreWeave 2.54Moderate Buy$136.7381.87% UpsideNBISNebius Group 2.60Moderate Buy$203.257.86% UpsideNVDANVIDIA 2.98Moderate Buy$304.2647.23% UpsideRXRXRecursion Pharmaceuticals 2.20Hold$8.10142.88% UpsideWRDWeRide 2.67Moderate Buy$12.48102.78% UpsideCurrent Analyst Ratings BreakdownLatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/14/2026ARMARM KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$300.00 ➝ $430.007/14/2026NVDANVIDIA KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$310.00 ➝ $330.007/14/2026ARMARM HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$255.00 ➝ $315.007/13/2026WRDWeRide Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)7/8/2026NVDANVIDIA Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)7/6/2026CRWVCoreWeave Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/2/2026CRWVCoreWeave Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$250.006/29/2026NVDANVIDIA Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/25/2026CRWVCoreWeave Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$250.006/24/2026CRWVCoreWeave Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/24/2026ARMARM TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$265.00 ➝ $475.00(Data available from 7/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPLDApplied Digital$144.19M54.64N/AN/A$2.21 per share12.47ARMARM$4.92B57.98$0.99 per share271.14$7.84 per share34.07CRWVCoreWeave$6.23B5.40$3.38 per share22.25$8.63 per share8.71NBISNebius Group$529.80M89.99N/AN/A$18.16 per share10.38NVDANVIDIA$215.94B23.16$4.80 per share43.08$6.47 per share31.94RXRXRecursion Pharmaceuticals$74.68M23.66N/AN/A$2.14 per share1.56WRDWeRide$97.89M19.54N/AN/A$3.39 per share1.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPLDApplied Digital-$231.07M-$0.74N/AN/AN/A-52.84%-15.91%-4.62%7/29/2026 (Estimated)ARMARM$904M$0.84319.03134.2210.8618.37%12.43%9.48%7/29/2026 (Estimated)CRWVCoreWeave-$1.17B-$3.11N/AN/AN/A-25.57%-43.07%-3.84%N/ANBISNebius Group$82.50M$3.1060.86N/AN/A95.27%-9.11%-3.73%8/6/2026 (Estimated)NVDANVIDIA$120.07B$6.5331.6717.260.4562.97%96.94%72.16%8/26/2026 (Estimated)RXRXRecursion Pharmaceuticals-$644.76M-$1.20N/AN/AN/A-842.95%-54.33%-40.60%8/4/2026 (Estimated)WRDWeRide-$230.20M-$0.75N/AN/AN/A-228.47%-24.18%-21.45%N/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026NBISNebius Group-$0.5634N/AN/AN/A$580.29 millionN/A8/4/2026Q2 2026RXRXRecursion Pharmaceuticals-$0.25N/AN/AN/A$10.97 millionN/A7/29/2026Q4 2026APLDApplied Digital-$0.20N/AN/AN/A$92.56 millionN/A7/29/2026Q1 2027ARMARM$0.40N/AN/AN/A$1.26 billionN/A5/20/2026Q1 2027NVDANVIDIA$1.76$1.87+$0.11$2.39$78.42 billion$81.62 billion5/14/2026Q1 2026NBISNebius Group-$0.81-$0.23+$0.58$2.11$375.13 million$399.00 million5/13/2026Q1 2026WRDWeRideN/A-$0.17N/A-$0.17N/A$16.55 million5/7/2026Q1 2026CRWVCoreWeave-$1.17-$1.40-$0.23-$1.40N/A$2.08 billion5/6/2026Q4 2026ARMARM$0.58$0.60+$0.02$0.29$1.47 billion$1.49 billion5/6/2026Q1 2026RXRXRecursion Pharmaceuticals-$0.30-$0.22+$0.08-$0.22$15.78 million$6.47 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPLDApplied DigitalN/AN/AN/AN/AN/AARMARMN/AN/AN/AN/AN/ACRWVCoreWeaveN/AN/AN/AN/AN/ANBISNebius GroupN/AN/AN/AN/AN/ANVDANVIDIA$1.000.48%+14.87%15.31%1 YearsRXRXRecursion PharmaceuticalsN/AN/AN/AN/AN/AWRDWeRideN/AN/AN/AN/AN/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2026NVDANVIDIAquarterly$0.250.46%6/4/20266/4/20266/26/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPLDApplied Digital1.652.382.38ARMARMN/A6.006.00CRWVCoreWeave3.680.310.31NBISNebius Group1.168.338.33NVDANVIDIA0.043.442.85RXRXRecursion Pharmaceuticals0.015.475.47WRDWeRideN/A7.637.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPLDApplied Digital65.67%ARMARM7.53%CRWVCoreWeaveN/ANBISNebius Group21.90%NVDANVIDIA65.27%RXRXRecursion Pharmaceuticals89.06%WRDWeRideN/AInsider OwnershipCompanyInsider OwnershipAPLDApplied Digital9.50%ARMARMN/ACRWVCoreWeave24.20%NBISNebius GroupN/ANVDANVIDIA3.94%RXRXRecursion Pharmaceuticals6.65%WRDWeRideN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPLDApplied Digital121285.77 million258.62 millionOptionableARMARM9,5841.07 billionN/ANot OptionableCRWVCoreWeave2,189447.57 million339.26 millionN/ANBISNebius Group1,543253.02 millionN/AN/ANVDANVIDIA42,00024.20 billion23.25 billionOptionableRXRXRecursion Pharmaceuticals400529.91 million494.67 millionOptionableWRDWeRide3,801310.68 millionN/AN/ANVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX HeadlinesRecent News About These CompaniesSumitomo Mitsui Trust Group Inc. Raises Position in WeRide Inc. $WRDJuly 14 at 5:11 AM | marketbeat.comWall Street Bullish on WeRide (WRD) Due to Partnerships and ExpansionJuly 13 at 7:28 PM | insidermonkey.comWeRide Secures HKEX Waiver to Restructure Founders’ Holdings via Family TrustsJuly 13 at 8:51 AM | tipranks.comWeRide Accelerates Global Expansion of Its End-to-End Intelligent Driving SolutionJuly 13 at 3:45 AM | globenewswire.comWeRide (WRD), Geely Farizon, and Kwoon Chung Bus Partner for Right-Hand-Drive RobotaxisJuly 10, 2026 | insidermonkey.comWeRide Inc. 2026 Q1 - Results - Earnings Call PresentationJuly 10, 2026 | seekingalpha.comWeRide Reports June 2026 Share Repurchases and Confirms Public Float ComplianceJuly 7, 2026 | tipranks.comWeRide (WRD), Uber (UBER) Announce Commercial Robotaxi Launch in ZurichJuly 4, 2026 | finance.yahoo.comWeRide Reports June 30 Share Buyback and Updates Hong Kong Disclosure ReturnJuly 2, 2026 | tipranks.comWeRide Launches Share Buyback, Adds Over 1.2 Million Shares to TreasuryJune 29, 2026 | tipranks.comWeRide Inc. Announces Adoption of All Proposed Resolutions at 2026 Annual General MeetingJune 26, 2026 | quiverquant.comQWeRide Inc. Announces Results of Annual General MeetingJune 26, 2026 | globenewswire.comWeRide Shareholders Approve All Resolutions at 2026 AGMJune 26, 2026 | tipranks.comWeRide GENESIS Named “Generative AI Platform of the Year,” Following ATTI Simulation Innovation AwardJune 25, 2026 | globenewswire.comWeRide, Geely Farizon and Kwoon Chung Launch Right-Hand-Drive Robotaxis at the 2026 International Automotive & Supply Chain Expo (Hong Kong), Accelerating Global ExpansionJune 22, 2026 | globenewswire.comWeRide and Uber expand robotaxi service to Zurich as European expansion continuesJune 17, 2026 | seekingalpha.comWhat's going on with WeRide stock Monday?June 15, 2026 | msn.comWeRide Achieves Record Six Consecutive Wins at China Urban Intelligent Driving CompetitionJune 15, 2026 | globenewswire.comTop Stocks Powering the Future of Electric and Self-Driving VehiclesJune 11, 2026 | zacks.comSlovak Prime Minister Meets WeRide, Signals Support for Multi-Product Autonomous Vehicle DeploymentJune 10, 2026 | globenewswire.comAnalysts Offer Insights on Consumer Cyclical Companies: FOOD & LIFE COMPANIES (OtherSGLOF), Honda Motor Co (OtherHNDAF) and WeRide (WRD)June 5, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese 5 Companies Just Made a Massive Bet on ThemselvesBy Thomas Hughes | June 15, 20262 AI Stocks That Could Benefit as AI Moves Beyond the Data CenterBy Thomas Hughes | July 5, 2026SpaceX Was Just the Beginning—2 More Massive IPOs Are on DeckBy Bridget Bennett | June 21, 2026Palantir’s Valuation Problem Just Met 2 New Growth CatalystsBy Chris Markoch | June 26, 20263 Biotech Firms With Major Potential Catalysts in the Coming MonthsBy Nathan Reiff | June 21, 2026NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Company DescriptionsApplied Digital NASDAQ:APLD$27.57 -0.90 (-3.17%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.Applied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services. The company was formerly known as Applied Blockchain, Inc. and changed its name to Applied Digital Corporation in November 2022. Applied Digital Corporation is based in Dallas, Texas.ARM NASDAQ:ARM$267.09 -14.08 (-5.01%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.CoreWeave NASDAQ:CRWV$75.18 -4.76 (-5.96%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.Nebius Group NASDAQ:NBIS$188.43 -5.66 (-2.92%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability. It also offers Avride, an autonomous driving solution which targets ride-hailing, logistics, e-commerce, and food/grocery delivery as application domains, as well as focuses on autonomous vehicles and delivery robots; and TripleTen, an EdTech service that prepares specialists for STEM roles, and equipping them with essential technology skills. The company was formerly known as Yandex N.V. and changed its name to Nebius Group N.V. in August 2024. Nebius Group N.V. was founded in 1989 and is based in Schiphol, the Netherlands.NVIDIA NASDAQ:NVDA$206.66 -5.14 (-2.43%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Recursion Pharmaceuticals NASDAQ:RXRX$3.34 -0.01 (-0.15%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.WeRide NASDAQ:WRD$6.16 +0.04 (+0.59%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.WeRide, Inc. engages in the development of an autonomous driving technology platform. It offers Robotaxi, Robobus, Robovan, Robosweeper, and advanced driving solutions, providing smart services in online ride-hailing, on-demand transport, urban logistics, and environmental sanitation. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s AI Spending Question Looms Over Q2 Earnings 3 Small-Cap Stocks Trading Under $10 With Room to Run Plot Twist: 12 States Could Stall the Paramount-Warner Bros. Discovery Mega-Merger 3 Gold Stocks Under $5 With Massive Upside CleanSpark Inks a $6.6B AI Lease to Become a Digital Landlord Tower Semiconductor’s AI Rally Is Built on a Light-Speed Bet Blueprint for a Billion: Nebius Group Secures the AI Floor Marriott vs. Viking: Why the Better Quarter Doesn't Mean the Better Decade Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
